Cargando…

Evaluation of adenomyosis after gonadotrophin-releasing hormone agonist therapy using ultrasound post-processing imaging: a pilot study

OBJECTIVE: We explored a method for the quantitative sonographic analysis of myometrial texture using computer-aided image analysis software to assess outcomes following treatment with gonadotrophin-releasing hormone (GnRH) agonist for adenomyosis in women with infertility. METHOD: Data for patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chou, Szu-Yuan, Chan, Cindy, Lee, Yu-Chieh, Yu, Tzu-Ning, Tzeng, Chii-Ruey, Chen, Chi-Huang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Retrospective Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297488/ https://www.ncbi.nlm.nih.gov/pubmed/32536293 http://dx.doi.org/10.1177/0300060520920056

Ejemplares similares

Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders
por: Xia, Min, et al.
Publicado: (2021)

Myopic Progression in Girls with Gonadotrophin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Chung, Seung Ah, et al.
Publicado: (2021)

The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles
por: Chen, Li, et al.
Publicado: (2023)

Gonadotrophin releasing hormone antagonist in IVF/ICSI
por: MS, Kamath, et al.
Publicado: (2008)

Review of Implant Gonadotrophin-Releasing Hormone Agonist Use: Experience in a Single Academic Center
por: Ni, Jennifer, et al.
Publicado: (2023)

Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy
por: Choi, Hee Jun, et al.
Publicado: (2023)

Decreased Level of Neurotrophic Factor Neuritin 1 in Women with Ovarian Endometriosis after Receiving Gonadotropin-Releasing Hormone Agonist Treatment
por: Rahmawati, Endah, et al.
Publicado: (2019)

Comparison of estrogen receptor-α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids
por: Kim, Eun Hee, et al.
Publicado: (2014)

Association between duration of gonadotrophin‐releasing hormone agonist use and cardiovascular risks: A population‐based competing‐risk analysis
por: Chan, Jeffrey S. K., et al.
Publicado: (2022)

Women with adenomyosis are at higher risks of endometrial and thyroid cancers: A population-based historical cohort study
por: Yeh, Chih-Ching, et al.
Publicado: (2018)

Using automated imaging to interrogate gonadotrophin-releasing hormone receptor trafficking and function
por: Armstrong, S.P., et al.
Publicado: (2011)

Relugolix: A new kid on the block among gonadotrophin-releasing hormone antagonists
por: Fragkoulis, Charalampos, et al.
Publicado: (2021)

Effectiveness of gonadotrophin-releasing hormone agonist therapy to improve the outcomes of intrauterine insemination in patients suffering from stage I-II endometriosis
por: Zhang, Kemei, et al.
Publicado: (2022)

Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer
por: Wang, Yu, et al.
Publicado: (2023)

The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK
por: Rosario, Derek J., et al.
Publicado: (2016)

Gonadotrophin-releasing hormone agonist-induced pituitary adenoma apoplexy and casual finding of a parathyroid carcinoma: A case report and review of literature
por: Triviño, Vanessa, et al.
Publicado: (2019)

Temporal and Spatial Regulation of CRE Recombinase Expression in Gonadotrophin-Releasing Hormone Neurones in the Mouse
por: Wolfe, A, et al.
Publicado: (2008)

Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis
por: Li, Muzi, et al.
Publicado: (2021)

Clinical effectiveness and potential long-term benefits of high-intensity focused ultrasound therapy for patients with adenomyosis
por: Li, Wei, et al.
Publicado: (2020)

Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment
por: Park, Chan Woo, et al.
Publicado: (2016)

The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors.
por: Qayum, A., et al.
Publicado: (1990)

Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes
por: Qi, Qianrong, et al.
Publicado: (2020)

Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts
por: Jacobs, E, et al.
Publicado: (1999)

Research Note: Polymorphisms of gonadotrophin-releasing hormone gene and their association with growth traits in quail (Coturnix Coturnix)
por: Wang, Xinle, et al.
Publicado: (2022)

Mature cystic teratoma arising from the fimbrial end of the left fallopian tube. a case report
por: Chou, Szu-Yuan, et al.
Publicado: (2019)

Efficacy of Combined Levonorgestrel-Releasing Intrauterine System with Gonadotropin-Releasing Hormone Analog for the Treatment of Adenomyosis
por: Zhang, Peihai, et al.
Publicado: (2013)

Gonadotrophins: The future
por: Patil, Madhuri
Publicado: (2014)

Serum levels of cancer antigen 125 before hormone replacement therapy are not associated with clinical outcome of frozen embryo transfer in women with adenomyosis
por: Huang, Ling, et al.
Publicado: (2021)

Plasmid DNA vaccine coding eight repeats of gonadotrophin-releasing hormone induced atrophy of prostate in male mice
por: Rima, Umme K., et al.
Publicado: (2018)

Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women
por: Bahaeldein, E, et al.
Publicado: (2018)

Interplay between nitric oxide and gonadotrophin-releasing hormone in the neuromodulation of the corpus luteum during late pregnancy in the rat
por: Vallcaneras, Sandra, et al.
Publicado: (2022)

Optimizing estradiol level for gonadotrophin-releasing hormone antagonist initiation among patients with simple tubal factor infertility
por: Wang, Yizhuo, et al.
Publicado: (2022)

The value of anti-Müllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments
por: Anckaert, Ellen, et al.
Publicado: (2012)

Fertility and Obstetric Outcomes of Assisted Reproductive Technology (ART) in Women With Adenomyosis Following Gonadotropin-Releasing Hormone Agonist Therapy: A Single-Center Experience
por: Rao, Asha R, et al.
Publicado: (2023)

Pregnancy outcomes in women with adenomyosis, undergoing artificial endometrial preparation with and without gonadotropin-releasing hormone agonist pretreatment in frozen embryo transfer cycles: An RCT
por: Eslami Moayed, Marzieh, et al.
Publicado: (2023)

The impact of phthalate on reproductive function in women with endometriosis
por: Chou, Ya‐Ching, et al.
Publicado: (2021)

Gonadotrophin-Releasing Hormone (GnRH) Analogues in the Treatment of Mixed Mullerian Tumours of the Uterus: Two Case Reports and Review
por: Katesmark, Michael, et al.
Publicado: (1998)

The correlation of anandamide with gonadotrophin and sex steroid hormones during the menstrual cycle
por: Cui, Na, et al.
Publicado: (2017)

Three-dimensional ultrasound manifestations of adenomyosis
por: Ahmadi, Firoozeh, et al.
Publicado: (2013)

Comparison of Clinical Efficacy between a Single Administration of Long-Acting Gonadotrophin-Releasing Hormone Agonist (GnRHa) and Daily Administrations of Short-Acting GnRHa in In Vitro Fertilization-Embryo Transfer Cycles
por: Cheon, Kang Woo, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_7o4gjjn1bqscs9pka1etlu29es